Cell-based Assay Market is expanding at $10,617 Million by 2023, says AMR

The global cell-based assay market was valued at $3,625 million in 2016, and is projected to reach $10,618 million by 2023, growing at a CAGR of 16.5% from 2017 to 2023. The consumables product segment accounted for nearly three-fifths share of the market in 2016.

The report offers information on the drivers, restraints, & opportunities, top investment pockets, market segments, market size & share, and the competitive landscape. These insights are helpful for market players, investors, stakeholders, and new entrants to gain major market share and international presence.

Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/4425

Cell-based assays include various assays that measure cell parameters such as cytotoxicity, proliferation, label generation, activation of specific signaling pathways, motility and morphology changes.

This method is ideal for miniaturization because it depends on reporter gene analysis with high sensitivity due to the signal amplification of the cell signaling system. Cell-based assays are widely applied to high throughput screening (HTS) formats.

The report elaborately analyzes the drivers, restraints, and opportunities of the cell-based assay market. Factors such as technological advancements in cell-based assays methodologies, surge in cell-based applications in drug discovery, adoption of high-throughput screening methods, and increase in R&D investment drive the growth of the market. However, high cost of the assays and dearth of skilled professionals hinder the growth of the market. Conversely, high adoption of label-free cell-based assays and untapped potential in developing countries offer significant growth opportunities to the market players.

The report presents a detailed analysis of the segments of the market. The market is classified into product, application, end user, and geography. Based on product, the study is bifurcated into consumable, instrument, service, and software. The consumables segment captures the highest market share due to their sheer usage and need throughout the pre-requisite steps of cell-based assay methodologies. Based on application, the market is divided into drug discovery; basic research; absorption, distribution, metabolism, & excretion (ADME) studies; predictive toxicology; and others. The drug discovery segment is likely to lead the cell-based assay market in terms of revenue through the forecast period, and it grabbed more than one-third of the total share in 2016.

The end user segment is bifurcated into pharmaceutical & biotechnology companies, academic & government research institutes, contract research organizations, and others. The pharmaceutical companies segment dominates the end-user segment. It is likely to grow at a CAGR of 14.6% from 2017 to 2023. Regionally, the market analysis covers North America, Europe, Asia-Pacific, and LAMEA.

A broad analysis of the players operating in the market is also offered in the study. Details such as their overview, their business segments under operation, key strategic moves and developments, and more are explained. The companies profiled in the report include Becton, Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific, Inc., General Electric Company, Merck KGaA, Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Lonza Group Ltd., Cell Signaling Technology, Inc., and Promega Corporation.

Flat 20% Discount on All License Type .. https://www.alliedmarketresearch.com/checkout/609468
*Offer Valid Till 20th April 2019

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client's insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.